Fibrocell Science Inc (FCSC)
Fibrocell Science is an autologous cell and gene therapy company focused on translating personalized biologics for diseases affecting the skin and connective tissue. Co.'s development programs consist of the following: FCX-007, which is a genetically-modified autologous fibroblast that encodes the gene for type VII collagen for localized treatment of recessive dystrophic epidermolysis bullosa; FCX-013, which is an autologous fibroblast genetically-modified using lentivirus and encoded for matrix metalloproteinase 1; and Gene Therapy Research Program, which is in the research phase and is focused on the treatment of arthritis and related conditions.
|
March 28, 2024 7:12 AM Eastern
Hold (2.00 out of 4)
100th percentile
|
|